-
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
(PAR-21-225)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Standard dates apply
The first standard due date for this FOA isSeptember 6, 2021
-
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
(PAR-21-226)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Standard dates apply
The first standard due date for this FOA is September 5, 2021
-
Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed)
(PAR-21-227)
National Institute of General Medical Sciences
Application Receipt Date(s): September 24, 2021
-
Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)
(RFA-AI-21-017)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 08, 2021
-
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional)
(RFA-DA-22-001)
National Institute on Drug Abuse
Application Receipt Date(s): August 13, 2021
-
Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional)
(RFA-DE-22-002)
National Institute of Dental and Craniofacial Research
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): July 08, 2021
-
NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed)
(RFA-DK-21-023)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): September 1, 2021
-
Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional
(RFA-FD-21-035)
Food and Drug Administration
Application Receipt Date(s): uly 6, 2021 by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
(RFA-MH-21-175)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Translational Neural Devices (UG3/UH3 - Clinical Trial Optional)
(RFA-NS-21-021)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
-
Translational Neural Devices (U44 Clinical Trial Optional)
(RFA-NS-21-022)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 1, 2021; October 20, 2021; February 18, 2022; June 20, 2022; October 18, 2022; February 21, 2023; June 19, 2023; October 18, 2023; February 20, 2024
-
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
(RFA-RM-21-018)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): September 03, 2021